United States Biotechnology & Medical Research

Channel Therapeutics Corp (CHRO)

Track

Over the past 90 days, Channel Therapeutics Corp recorded 12 insider transactions. Activity was characterized by a significant purchase of approximately $1 million by Todd C. Davis in June, contrasted by multiple planned sales from other insiders. These transactions follow a recent earnings report where the company missed EPS expectations by 26.087%.
Ticker: CHRO Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Channel Therapeutics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 2 Jul 2026
Value US$1,329,035.25 | Price 307.41 | Shares 40,692 (+23.5%)
Planned sale 2 Jul 2026
Value US$1,276,539.19 | Price 491.62 | Shares 63,012 (-0.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-02 PlS Planned sale
2.8
Pauls Matthew
Non-Executive Director
40,692 +23.5%
307.41
US$1,329,035 		40,692 +23.5% 307.41 US$1,329,035
2026-07-07 2026-07-02 PlS Planned sale
2.8
Pauls Matthew
Non-Executive Director
63,012 -0.5%
491.62
US$1,276,539 		63,012 -0.5% 491.62 US$1,276,539
2026-07-07 2026-07-02 PlS Planned sale
2.5
Greenleaf Peter
Non-Executive Director
23,897 -8.9%
76.29
US$230,595 		23,897 -8.9% 76.29 US$230,595
2026-07-07 2026-07-02 PlS Planned sale
2.5
Greenleaf Peter
Non-Executive Director
712 -2.9%
26.00
US$18,509 		712 -2.9% 26.00 US$18,509
2026-07-07 2026-07-02 PlS Planned sale
Friedberg Ezra M
Non-Executive Director
24 -0.0%
27.33
US$656 		24 -0.0% 27.33 US$656
2026-07-07 2026-07-02 PlS Planned sale
Friedberg Ezra M
Non-Executive Director
534 -0.7%
26.03
US$13,900 		534 -0.7% 26.03 US$13,900
2026-06-17 2026-06-15 PlS Planned sale
Friedberg Ezra M
Non-Executive Director
59 -0.1%
27.94
US$1,648 		59 -0.1% 27.94 US$1,648
2026-06-17 2026-06-15 PlS Planned sale
Friedberg Ezra M
Non-Executive Director
224 -0.3%
27.12
US$6,076 		224 -0.3% 27.12 US$6,076
2026-06-15 2026-06-11 B Purchase
4.0
Davis Todd C
Non-Executive Director
503 +0.7%
28.73
US$14,449 		503 +0.7% 28.73 US$14,449
2026-06-15 2026-06-11 B Purchase
4.0
Davis Todd C
Non-Executive Director
35,445 +88.9%
27.80
US$985,534 		35,445 +88.9% 27.80 US$985,534
2026-05-26 2026-05-22 S Sale
1.3
Francis Knuettel II

CFO, Treas & Secty

Officer
1,500 -11.7%
26.84
US$40,265 		1,500 -11.7% 26.84 US$40,265
2026-05-22 2026-05-22 PrS Proposed sale
1.3
Francis Knuettel II

Officer

Officer
1,720
27.11
US$46,629 		1,720 27.11 US$46,629
2026-04-06 2026-04-02 PlS Planned sale
2.8
Pauls Matthew
Non-Executive Director
371 -2.4%
21.36
US$7,926 		371 -2.4% 21.36 US$7,926
2026-04-06 2026-04-02 PlS Planned sale
2.8
Pauls Matthew
Non-Executive Director
415 -2.6%
20.52
US$8,514 		415 -2.6% 20.52 US$8,514
2026-04-06 2026-04-02 PlS Planned sale
0.7
Malamut Richard
Non-Executive Director
280 -1.0%
21.36
US$5,981 		280 -1.0% 21.36 US$5,981
2026-04-06 2026-04-02 PlS Planned sale
0.7
Malamut Richard
Non-Executive Director
310 -1.1%
20.51
US$6,359 		310 -1.1% 20.51 US$6,359
2026-04-06 2026-04-02 PlS Planned sale
2.5
Greenleaf Peter
Non-Executive Director
377 -1.5%
21.36
US$8,053 		377 -1.5% 21.36 US$8,053
2026-04-06 2026-04-02 PlS Planned sale
2.5
Greenleaf Peter
Non-Executive Director
420 -1.6%
20.52
US$8,616 		420 -1.6% 20.52 US$8,616
2026-04-06 2026-04-02 PlS Planned sale
Friedberg Ezra M
Non-Executive Director
265 -0.3%
21.36
US$5,661 		265 -0.3% 21.36 US$5,661
2026-04-06 2026-04-02 PlS Planned sale
Friedberg Ezra M
Non-Executive Director
293 -0.4%
20.51
US$6,010 		293 -0.4% 20.51 US$6,010
2025-11-26 2025-11-25 S Sale
Friedberg Ezra M
Non-Executive Director
2,000 -6.2%
28.01
US$56,010 		2,000 -6.2% 28.01 US$56,010
2025-11-26 2025-11-25 S Sale
Friedberg Ezra M
Non-Executive Director
1 -0.0%
28.50
US$28 		1 -0.0% 28.50 US$28
2025-11-26 2025-11-25 S Sale
Friedberg Ezra M
Non-Executive Director
2,000 -5.9%
28.14
US$56,270 		2,000 -5.9% 28.14 US$56,270
2025-11-26 2025-11-25 S Sale
Friedberg Ezra M
Non-Executive Director
5,999 -15.0%
28.00
US$167,972 		5,999 -15.0% 28.00 US$167,972
2024-09-16 2024-09-13 B Purchase
1.3
Francis Knuettel II

CEO, Pres., CFO, Treas & Secty

Officer
3,500 +0.6%
0.97
US$3,395 		3,500 +0.6% 0.97 US$3,395
2024-09-16 2024-09-12 B Purchase
1.3
Francis Knuettel II

CEO, Pres., CFO, Treas & Secty

Officer
1,700 +0.3%
0.97
US$1,649 		1,700 +0.3% 0.97 US$1,649
2024-09-16 2024-09-12 B Purchase
0.7
Malamut Richard
Non-Executive Director
10,400 +12.8%
0.94
US$9,825 		10,400 +12.8% 0.94 US$9,825
2024-09-12 2024-09-11 B Purchase
1.3
Francis Knuettel II

CEO, Pres., CFO, Treas & Secty

Officer
5,500 +1.0%
0.94
US$5,170 		5,500 +1.0% 0.94 US$5,170
2024-09-12 2024-09-10 B Purchase
1.3
Francis Knuettel II

CEO, Pres., CFO, Treas & Secty

Officer
6,500 +1.2%
0.89
US$5,785 		6,500 +1.2% 0.89 US$5,785
Explore more

More insider trading research around Channel Therapeutics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America